Non-invasive monitoring of spontaneous and antiarrhythmic drug induced changes in fibrillatory frequency in human atrial fibrillation

Computers in Cardiology

Volumn , Issue , 1999, Pages 695-698

  Bollmann, Andreas ^a,b   Sonne, K ^a   Wodarz, K ^a   Esperer, H D ^a   Toepffer, I ^a   Klein, H U ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INTERACTIONS; FOURIER TRANSFORMS; MEDICAL COMPUTING; MEDICAL PROBLEMS; NONINVASIVE MEDICAL PROCEDURES; PATTERN RECOGNITION;

ANTIARRHYTHMIC DRUGS; ATRIAL FIBRILLATORY FREQUENCY; HUMAN ATRIAL FIBRILLATION;

ELECTROCARDIOGRAPHY;

EID: 0033282480     PISSN: 02766574     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (24)

1. Moe G. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-8.
2. Allessie MA, Lammers WJPE, Bonke FIM, Hollen J. Experimental evaluation af Moe's multiple wavelet hypothesis of AF. New York: Grune & Stratton; 1985.
3. Bollmann A, Kanuru NK, McTeague KK, et al. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81(12):1439-45.
4. Holm M, Pehrson S, Ingemansson M, et al. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38(1):69-81.
5. Slocum J, Sahakian A, Swiryn S. Diagnosis of atrial fibrillation from surface electrocardiograms based on computer-detected atrial activity. J Electrocardiol 1992;25(1):1-8.
6. Ramdat Misier AR, Opthof T, van Hemel NM, et al. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992;19(7):1531-5.
7. Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995;92(5):1193-202.
8. Cinca J, Moya A, Figueras J, Roma F, Rius J. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. Am Heart J 1986;112(2):315-21.
9. Huikuri HV, Yli-Mayry S, Linnaluoto MK, Ikaheimo MJ. Diurnal fluctuations in human ventricular and atrial refractoriness. PACE 1995;18(7):1362-8.
10. Ropella KM, Sahakian AV, Baerman JM, Swiryn S. Effects of procainamide on intra-atrial electrograms during atrial fibrillation: implications for detection algorithms. Circulation 1988;77(5):1047-54.
11. Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990;16(6):1408-14.
12. Sih HJ, Ropella KM, Swiryn S, Gerstenfeld EP, Sahakian AV. Observations from intraatrial recordings on the termination of electrically induced atrial fibrillation in humans. PACE 1994;17(7):1231-42.
13. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96(12):4298-306.
14. Asano Y, Saito J, Matsumoto K, et al. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992;69(12):1033-8.
15. Brugada J, Gursoy S, Brugada P. et al. Cibenzoline transforms random re-entry into ordered re-entry in the atria. Eur Heart J 1993;14(2):267-72.
16. Biffi M, Boriani G, Bronzetti G, et al. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart 1999;82(2):176-82.
17. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92(7):1954-68.
18. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998;98(20):2202-9.
19. Prystowsky EN, Naccarelli GV, Jackman WM, et al. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 1983;51(1):96-100.
20. Shimizu W, Tsuchioka Y, Karakawa S, et al. Differential effect of pharmacological autonomie blockade on some electrophysiological properties of the human ventricle and atrium. Br Heart J 1994;71(1):34-7.
21. Leitch JW, Basta M, Fletcher PJ. Effect of phenylephrine infusion on atrial electrophysiological properties. Heart 1997;78(2):166-70.
22. Ingemansson MP, Holm M, Olsson SB. Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation. Heart 1998;80(1):71-6.
23. Wang J, Bourne GW, Wang Z, et al. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993;88(3):1030-44.
24. Wijffels MC, Dorland R, Allessie MA. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol 1999;10(2):178-93.